145 related articles for article (PubMed ID: 28436711)
21. MiR-204 regulates HMGA2 expression and inhibits cell proliferation in human thyroid cancer.
Wu ZY; Wang SM; Chen ZH; Huv SX; Huang K; Huang BJ; Du JL; Huang CM; Peng L; Jian ZX; Zhao G
Cancer Biomark; 2015; 15(5):535-42. PubMed ID: 26406941
[TBL] [Abstract][Full Text] [Related]
22. Tumor suppressor miR-33b-5p regulates cellular function and acts a prognostic biomarker in RCC.
Huang G; Lai Y; Pan X; Zhou L; Quan J; Zhao L; Li Z; Lin C; Wang J; Li H; Yuan H; Yang Y; Lai Y; Ni L
Am J Transl Res; 2020; 12(7):3346-3360. PubMed ID: 32774704
[TBL] [Abstract][Full Text] [Related]
23. miR-17-5p/20a are important markers for gastric cancer and murine double minute 2 participates in their functional regulation.
Wang M; Gu H; Qian H; Zhu W; Zhao C; Zhang X; Tao Y; Zhang L; Xu W
Eur J Cancer; 2013 May; 49(8):2010-21. PubMed ID: 23333058
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-582-5p suppressed gastric cancer cell proliferation via targeting AKT3.
Jin Y; Tao LP; Yao SC; Huang QK; Chen ZF; Sun YJ; Jin SQ
Eur Rev Med Pharmacol Sci; 2017 Nov; 21(22):5112-5120. PubMed ID: 29228422
[TBL] [Abstract][Full Text] [Related]
25. Increasing miR-150 and lowering HMGA2 inhibit proliferation and cycle progression of colon cancer in SW480 cells.
Zhang ZC; Wang GP; Yin LM; Li M; Wu LL
Eur Rev Med Pharmacol Sci; 2018 Oct; 22(20):6793-6800. PubMed ID: 30402842
[TBL] [Abstract][Full Text] [Related]
26. miR-195 Regulates Proliferation and Apoptosis through Inhibiting the mTOR/p70s6k Signaling Pathway by Targeting HMGA2 in Esophageal Carcinoma Cells.
Li Y; Wu D; Wang P; Li X; Shi G
Dis Markers; 2017; 2017():8317913. PubMed ID: 28487599
[TBL] [Abstract][Full Text] [Related]
27. Upregulation of miR-501-5p activates the wnt/β-catenin signaling pathway and enhances stem cell-like phenotype in gastric cancer.
Fan D; Ren B; Yang X; Liu J; Zhang Z
J Exp Clin Cancer Res; 2016 Nov; 35(1):177. PubMed ID: 27846906
[TBL] [Abstract][Full Text] [Related]
28. HMGA2 regulates lung cancer proliferation and metastasis.
Gao X; Dai M; Li Q; Wang Z; Lu Y; Song Z
Thorac Cancer; 2017 Sep; 8(5):501-510. PubMed ID: 28752530
[TBL] [Abstract][Full Text] [Related]
29. Targeting the HMGA2 oncogene by miR-498 inhibits non-small cell lung cancer biological behaviors.
Gao N; Wang FX; Wang G; Zhao QS
Eur Rev Med Pharmacol Sci; 2018 Mar; 22(6):1693-1699. PubMed ID: 29630114
[TBL] [Abstract][Full Text] [Related]
30. [Suppression of miR-30a/HMGA2-mediated autophagy in osteosarcoma cells impacts chemotherapeutics-induced apoptosis].
Xia Q; Ni J; Huang J; Pan B; Yan M; Li W
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Jul; 44(7):757-766. PubMed ID: 31413213
[TBL] [Abstract][Full Text] [Related]
31. [MicroRNA-33b inhibits cell proliferation in hepatocellular carcinoma via targeting SALL4].
Li Y; Li R; Fu X; Zhou W; Peng S; Fu L
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):905-10. PubMed ID: 27640788
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of let-7a-5p predicts lymph node metastasis and prognosis in colorectal cancer: Implications for chemotherapy.
Liu TP; Huang CC; Yeh KT; Ke TW; Wei PL; Yang JR; Cheng YW
Surg Oncol; 2016 Dec; 25(4):429-434. PubMed ID: 27262492
[TBL] [Abstract][Full Text] [Related]
33. miR-145, targeting high-mobility group A2, is a powerful predictor of patient outcome in ovarian carcinoma.
Kim TH; Song JY; Park H; Jeong JY; Kwon AY; Heo JH; Kang H; Kim G; An HJ
Cancer Lett; 2015 Jan; 356(2 Pt B):937-45. PubMed ID: 25444913
[TBL] [Abstract][Full Text] [Related]
34. miR-15b and miR-16 modulate multidrug resistance by targeting BCL2 in human gastric cancer cells.
Xia L; Zhang D; Du R; Pan Y; Zhao L; Sun S; Hong L; Liu J; Fan D
Int J Cancer; 2008 Jul; 123(2):372-379. PubMed ID: 18449891
[TBL] [Abstract][Full Text] [Related]
35. miR-129-5p attenuates cell proliferation and epithelial mesenchymal transition via HMGB1 in gastric cancer.
Wang S; Chen Y; Yu X; Lu Y; Wang H; Wu F; Teng L
Pathol Res Pract; 2019 Apr; 215(4):676-682. PubMed ID: 30635217
[TBL] [Abstract][Full Text] [Related]
36. RKIP suppresses the proliferation and metastasis of breast cancer cell lines through up-regulation of miR-185 targeting HMGA2.
Zou Q; Wu H; Fu F; Yi W; Pei L; Zhou M
Arch Biochem Biophys; 2016 Nov; 610():25-32. PubMed ID: 27651238
[TBL] [Abstract][Full Text] [Related]
37. MicroRNA-33b-5p is overexpressed and inhibits GLUT4 by targeting HMGA2 in polycystic ovarian syndrome: An in vivo and in vitro study.
Yang Y; Jiang H; Xiao L; Yang X
Oncol Rep; 2018 Jun; 39(6):3073-3085. PubMed ID: 29693142
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-98 targets HMGA2 to inhibit the development of retinoblastoma through mediating Wnt/β-catenin pathway.
Li W; Wang J; Zhang D; Zhang X; Xu J; Zhao L
Cancer Biomark; 2019; 25(1):79-88. PubMed ID: 31033463
[TBL] [Abstract][Full Text] [Related]
39. MiR-33b inhibits osteosarcoma cell proliferation through suppression of glycolysis by targeting Lactate Dehydrogenase A (LDHA).
Zheng XM; Xu CW; Wang F
Cell Mol Biol (Noisy-le-grand); 2018 Aug; 64(11):31-35. PubMed ID: 30213286
[TBL] [Abstract][Full Text] [Related]
40. MicroRNA-497-5p stimulates osteoblast differentiation through HMGA2-mediated JNK signaling pathway.
Zhao H; Yang Y; Wang Y; Feng X; Deng A; Ou Z; Chen B
J Orthop Surg Res; 2020 Nov; 15(1):515. PubMed ID: 33168056
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
